Searched for
MHLW
Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilarIn a significant advancement, Biocon Biologics has gained marketing approval for its pegfilgrastim biosimilar in Japan. This vital cancer s...- Discovery, development, dedicated centres and manufacturing biz contribute to Syngene growth: Jonathan Hunt“$100-120 million capex will be for a little bit of catch-up and the rest of it will be investment in the future growth of the company.”
- Japan lifts inspection order for black tiger shrimps from IndiaBlack tiger shrimp, commonly known as the giant tiger prawn or Asian tiger shrimp, is a popular seafood delicacy the world over and also fo...
- On Twitter, SoftBank’s Son says will ‘take action’ against CoronavirusMany of Son's past tweets are company-focused although it was not his first time to touch on societal issues. In 2014, he tweeted a video o...
- Biocon's partner firm launches diabetes product in JapanIn March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
- Biocon gets nod to sell its diabetes product 'Insulin Glargine' in JapanBiocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country.
- Japan fixes MRL for ethoxyquin in shrimps; brings relief to Indian marine exportersJapan's health ministry has officially notified the MRL for ethoxyquin in shrimps. It has been fixed at 0.2 ppm in crustaceans including fa...
- Ranbaxy launches generic Amlodipine tablets in JapanPharma major Ranbaxy said it has launched hypertension drug Amlodipine tablets in Japan.
Load More